INS and type 2 diabetes mellitus: Recent evidence, in particular, suggests that a lower threshold for glucose-stimulated insulin release can set in motion the vicious circle between insulin resistance and hyperinsulinemia, leading eventually to beta cell decompensation and T2D (Cohrs et al, 2020; Johnson, 2021).